{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:04:13Z","timestamp":1759230253228},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.patbio.2003.09.012","type":"journal-article","created":{"date-parts":[[2004,2,28]],"date-time":"2004-02-28T10:31:43Z","timestamp":1077964303000},"page":"66-75","source":"Crossref","is-referenced-by-count":20,"title":["L\u2019amphot\u00e9ricine B liposomale en prophylaxie secondaire chez les patients VIH+ atteints de leishmaniose visc\u00e9rale\u00a0: \u00e0 propos de cinq cas"],"prefix":"10.1016","volume":"52","author":[{"given":"M","family":"Montana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Chochoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Monges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Ravaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Faraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gensollen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C","family":"Bongrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Timon-David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Gallais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2003.09.012_BIB1","unstructured":"Rapport OMS no 116\u00a0r\u00e9vis\u00e9 Mai 2000 available from: URL: http:\/\/www.who.int\/inf-fs\/fr\/am116.htlm."},{"key":"10.1016\/j.patbio.2003.09.012_BIB2","unstructured":"Basset D, Pratlong F, Ravel C, Puechberty J, Dereure J, Dedet JP\u00a0: \u00ab\u00a0Les leishmanioses d\u00e9clar\u00e9es en France en 1999\u00a0\u00bb, available from: URL: http:\/\/www.invs.sante.fr\/beh\/2001\/05\/arde1041.htm."},{"key":"10.1016\/j.patbio.2003.09.012_BIB3","first-page":"28","article-title":"\u00ab\u00a0Traitement de la leishmaniose visc\u00e9rale\u00a0: modalit\u00e9s r\u00e9centes\u00a0\u00bb","author":"Gangneux","year":"1999","journal-title":"La presse m\u00e9dicale"},{"issue":"2","key":"10.1016\/j.patbio.2003.09.012_BIB4","first-page":"191","article-title":"\u201cTreatment of mediterranean visceral leishmaniasis\u201d","volume":"73","author":"Gradoni","year":"1995","journal-title":"Bulletin of World health organization"},{"issue":"4","key":"10.1016\/j.patbio.2003.09.012_BIB5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","article-title":"\u201cClinicoepidemiologic characteristics, pronostic factors, and survival analysis of patients coinfected with HIV and Leishmania in an area of Madrid\u201d","volume":"58","author":"Lopez-Velez","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.patbio.2003.09.012_BIB6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"\u201cLeishmania and human immunodeficiency virus coinfection: the first 10\u00a0years\u201d","volume":"10","author":"Alvar","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"issue":"2","key":"10.1016\/j.patbio.2003.09.012_BIB7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02767767","article-title":"\u201cMediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical and diagnostic features of 22\u00a0cases\u201d","volume":"26","author":"Agostoni","year":"1998","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.patbio.2003.09.012_BIB8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/jinf.1999.0607","article-title":"\u201cLong term remission of HIV-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases\u201d","volume":"40","author":"Mastroianni","year":"2000","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.patbio.2003.09.012_BIB9","first-page":"193","article-title":"\u201cLeishmaniasis and human immunodeficicency virus\u00a0:an emerging co-infection?\u201d","volume":"59","author":"Marlier","year":"1999","journal-title":"Med Trop"},{"key":"10.1016\/j.patbio.2003.09.012_BIB10","doi-asserted-by":"crossref","unstructured":"Vidal 2002.","DOI":"10.1515\/semi.2002.035"},{"key":"10.1016\/j.patbio.2003.09.012_BIB11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0163-4453(90)93933-J","article-title":"\u201cVisceral leishmaniasis in patients infected with human immunodeficiency virus\u201d","volume":"21","author":"Montalban","year":"1990","journal-title":"J Infected"},{"key":"10.1016\/j.patbio.2003.09.012_BIB12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00002030-199102000-00011","article-title":"\u201cVisceral leishmaniasis\u00a0:another HIV-associated opportunistic infection\u00a0? Report of eight cases and review of litterature\u201d","volume":"50","author":"Altes","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.patbio.2003.09.012_BIB13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"\u201cVisceral leishmaniasis in patients infected with the human immunodefiency virus\u201d","volume":"16","author":"Laguna","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.patbio.2003.09.012_BIB14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01709465","article-title":"\u201cItraconazole as maintenance therapy for visceral leishmaniasis in HIV infected patients\u201d","volume":"17","author":"Angarano","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"14","key":"10.1016\/j.patbio.2003.09.012_BIB15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","article-title":"\u201cHIV viral load and response to antileishmanial chemotherapy in co-infected patients\u201d","volume":"13","author":"Behre","year":"1999","journal-title":"Aids"},{"issue":"9","key":"10.1016\/j.patbio.2003.09.012_BIB16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"\u201cTreatment of visceral leishmaniasis in HIV infected patients\u00a0: a randomized trial comparing meglumine antimoniate with amphotericin B\u201d","volume":"13","author":"Laguna","year":"1999","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.patbio.2003.09.012_BIB17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"\u201cIn vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate\u00a0: a study of 37\u00a0strains collected from patients with visceral leishmaniasis\u201d","volume":"41","author":"Faraut","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.patbio.2003.09.012_BIB18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0035-9203(95)90476-X","article-title":"\u201cVisceral leishmaniasis and HIV-1 co-infection in southern France\u201d","volume":"89","author":"Rosenthal","year":"1995","journal-title":"Trans R Soc Trop Me Hyg"},{"key":"10.1016\/j.patbio.2003.09.012_BIB19","unstructured":"Borelli P, Imperato A, Murdaca G, Scudeletti M: \u201cLiposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV\u201d, Ann Ital Med Int, 15(2), 169-71."},{"issue":"2","key":"10.1016\/j.patbio.2003.09.012_BIB20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-4453(98)80017-0","article-title":"\u201cVisceral leishmaniasis in two patients with HIV-1 infection\u00a0: atypical features and response to therapy\u201d","volume":"26","author":"Hamour","year":"1998","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.patbio.2003.09.012_BIB21","first-page":"384","article-title":"\u00ab\u00a0L\u2019amphot\u00e9ricine B dans les \u00e9mulsions lipidiques parent\u00e9rales. Stabilit\u00e9 gal\u00e9nique des m\u00e9langes","volume":"44","author":"Blancard","year":"1996","journal-title":"R\u00e9sultats pr\u00e9liminaires\u00a0\u00bb"},{"key":"10.1016\/j.patbio.2003.09.012_BIB22","first-page":"18","article-title":"\u00ab\u00a0Les liposomes\u00a0: structure, propri\u00e9t\u00e9s et comportement in vivo\u00a0\u00bb","author":"Devoiselles","year":"1999","journal-title":"La Lettre de l\u2019infectiologue"},{"key":"10.1016\/j.patbio.2003.09.012_BIB23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-4453(96)91343-2","article-title":"\u201cVisceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (Ambisome)\u201d","volume":"32","author":"Russo","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.patbio.2003.09.012_BIB24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/clinids\/19.2.362","article-title":"\u201cVisceral leishmaniasis following treatment with liposomal amphotericin B\u201d","volume":"19","author":"Mac Bride","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.patbio.2003.09.012_BIB25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinids\/17.4.625","article-title":"\u201cSuccessful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with HIV\u201d","volume":"17","author":"Torre-Cisneros","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.patbio.2003.09.012_BIB26","first-page":"75","article-title":"\u201cLiposomal amphotericin B (Ambisome) in Mediterranean visceral leishmaniasis\u00a0: a multi-centre trial\u201d","volume":"87","author":"Davidson","year":"1994","journal-title":"Quarterly Journal of Medicine"},{"issue":"suppl","key":"10.1016\/j.patbio.2003.09.012_BIB27","first-page":"s26","article-title":"\u201cLiposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds, International congress on drug therapy in HIV infection\u201d","volume":"6","author":"Lazanas","year":"1992","journal-title":"Scotland, AIDS"},{"key":"10.1016\/j.patbio.2003.09.012_BIB28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/515085","article-title":"\u201cUS Food and Drug Administration of Approval of Ambisome (liposomal amphotericin B) for Treatment of Visceral Leishmaniasis\u201d","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.patbio.2003.09.012_BIB29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","article-title":"\u201cProspective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly antiretroviral theapy\u201d","volume":"19","author":"Villanueva","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.patbio.2003.09.012_BIB30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0002-9343(92)90281-F","article-title":"\u201cMaintenance Itraconazole for visceral leishmaniasis in HIV infection\u201d","volume":"92","author":"Lafeuillade","year":"1992","journal-title":"A J Med"},{"key":"10.1016\/j.patbio.2003.09.012_BIB31","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/clinids\/21.5.1338","article-title":"\u201cUse of itraconazole\/allopurinol combination for treatment of visceral leishmaniasis in a patient with AIDS\u201d","volume":"21","author":"Raffi","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.patbio.2003.09.012_BIB32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/37.5.1042","article-title":"\u201cFluconazole plus allopurinol in the treatment for visceral leishmaniasis\u201d","volume":"37","author":"Torrus","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.patbio.2003.09.012_BIB33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9343(97)89503-4","article-title":"\u201cProphylaxis of visceral leishmaniasis in human immunodefiency virus infected patients\u201d","volume":"100","author":"Ribera","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.patbio.2003.09.012_BIB34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00001432-199812000-00010","article-title":"\u201cChanging patterns of disease and treatment of parasitic opportunistic infections\u201d","volume":"11","author":"Derouin","year":"1998","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.patbio.2003.09.012_BIB35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.1999.61.766","article-title":"\u201cHigh frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients\u201d","volume":"61","author":"Delgado","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.patbio.2003.09.012_BIB36","series-title":"\u00ab\u00a0Traitement de la leishmaniose visc\u00e9rale\u00a0: le point sur l\u2019int\u00e9r\u00eat et les limites de la milt\u00e9fosine\u00a0\u00bb","author":"Gangneux","year":"2001"},{"key":"10.1016\/j.patbio.2003.09.012_BIB37","series-title":"\u201cTreatment of VL\/HIV co-infected patients with oral miltefosine, Satellite symposium at the world Leish. II congress\u201d","author":"Fisher","year":"2001"},{"issue":"16","key":"10.1016\/j.patbio.2003.09.012_BIB38","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/00002030-199816000-00009","article-title":"\u201cVisceral leihmaniasis in HIV positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts\u201d","volume":"12","author":"Kubar","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.patbio.2003.09.012_BIB39","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1097\/00002030-200012220-00020","article-title":"\u201cDiscontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to higly active antiretroviral therapy\u201d","volume":"14","author":"Berenguer","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.patbio.2003.09.012_BIB40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/clinids\/21.3.711","article-title":"\u201cEfficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodefiency virus\u201d","volume":"21","author":"Laguna","year":"1995","journal-title":"Clin Infect Dis"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036981140300227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036981140300227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T06:55:39Z","timestamp":1585637739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036981140300227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S036981140300227X"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2003.09.012","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}